Results 191 to 197 of about 100,083 (197)

Suboptimal heart rate control despite beta-blocker use in coronary artery disease: evidence from the Fasa PERSIAN cohort. [PDF]

BMC Cardiovasc Disord
Yazdanpanah MH, Bazmi S, Fakhraei B, Bahramali E, Kazemi M, Zarenezhad E, Jaafari N, Rostaei S, Farjam M.   +8 more
europepmc   +1 more source

Impact of digoxin versus beta-blocker in patients with coexistent atrial fibrillation and heart failure: a target trial emulation. [PDF]

BMC Med
Liu L, Cai AP, Huang JY, Gu WL, Guo R, Zhang JN, Xuan HC, Chan YH, Xu AM, Cheung BMY, Lip GYH, Yiu KH.   +11 more
europepmc   +1 more source

A retrospective study on beta-blocker use and outcomes in hematopoietic stem cell transplant patients. [PDF]

PeerJ
Bergens MA, Bokman JT, Johnson EJ, Braun ML, Li Y, Bush AT, Hill L, Van Opstal J, Racioppi A, Fan R, Kaushik S, Alyea E, Chao N, Choi T, Gasparetto C, Horwitz M, Lopez R, Ramalingam S, Sullivan K, Wischmeyer P, Sung AD.   +20 more
europepmc   +1 more source

Beta-blocker therapy after myocardial infarction with preserved LVEF (≥50%): a systematic review and Bayesian meta-analysis with time-to-event reconstruction. [PDF]

Am Heart J Plus
Al-Shammari AS, Kurmasha YH, Islam MR, Hammadeh BM, Khaleel NI, Hamed BM, Altaii H, Jena N, Gerdes J, Sokos G, Daggubati R, Sattar Y, Refaat M.   +12 more
europepmc   +1 more source

Stabilizing Stable Coronary Artery Disease: No Beta-Blocker, No Problem? [PDF]

JACC Adv
Chi KY, Nanna MG.
europepmc   +1 more source